The 13th annual meeting of the British Society for Gene and Cell Therapy (BSGCT) reflected the huge interest currently being generated in use of adeno-associated virus as a therapeutic vector. The purpose of the shorter 1 day meeting was to focus in depth on particular topics that are pertinent to the scientific mission of our society. The local organising committee put together a fabulous programme showcasing aspects of AAV biology, use of AAV as a gene transfer and editing tool, and clinical application. We are particularly grateful to our speakers, international experts in the field, for accepting our invitation.
In addition to keynote lectures, we selected the best abstract submissions for short oral presentations, which were judged on the day for the BSGCT Fairbairn award. As is traditional with BSCGT meetings, we recognise the importance of creating opportunities for the next generation of scientific researchers to present their research.
The society is very grateful for the outstanding support for the meeting from our sponsors and exhibitors. Without this, we would not have been able to create such an exciting programme.
With thanks to our sponsors and partners